ETTX - Entasis Therapeutics Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Entasis Therapeutics Holdings's activity chart (see below) currently has 20 price targets and 22 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.36% with an average time for these price targets to be met of 10.62 days.

Most recent stock forecast was given by from SCOTIABANK on 06-May-2022. First documented stock forecast 22-Oct-2018.

Best performing analysts who are covering ETTX - Entasis Therapeutics Holdings:

Martin Auster Robert Driscoll Louise Chen Matthew Luchini Ed Arce James Molloy Jonathan Aschoff

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Sep-2020

$2

$-0.19 (-8.68%)

$5

4 years 2 months 7 days ago
(06-May-2022)

1/3 (33.33%)

$0.15 (8.11%)

17

Hold

$2

$-0.19 (-8.68%)

4 years 3 months 27 days ago
(16-Mar-2022)

1/1 (100%)

$0.11 (5.82%)

68

Buy Since 19-Oct-2021

$1.8

$-0.39 (-17.81%)

4 years 4 months 5 days ago
(08-Mar-2022)

1/2 (50%)

$0.15 (9.09%)

7

Buy Since 19-Aug-2019

$1.8

$-0.39 (-17.81%)

4 years 4 months 9 days ago
(04-Mar-2022)

1/4 (25%)

$0.05 (2.86%)

11

Buy Since 22-Oct-2018

$7

4 years 8 months 22 days ago
(21-Oct-2021)

0/2 (0%)

$3.76 (116.05%)

Show more analysts

Please expand the browser size to see the chart

What is ETTX (Entasis Therapeutics Holdings) average time for price targets to be met?

On average it took 10.62 days on average for the stock forecasts to be realized with a an average price target met ratio 24.36

Which analyst has the current highest performing score on ETTX (Entasis Therapeutics Holdings) with a proven track record?

MARTIN AUSTER

Which analyst has the most public recommendations on ETTX (Entasis Therapeutics Holdings)?

Martin Auster works at RAYMOND JAMES and has 10 price targets and 7 ratings on ETTX

Which analyst is the currently most bullish on ETTX (Entasis Therapeutics Holdings)?

Jonathan Aschoff with highest potential upside - $5.81

Which analyst is the currently most reserved on ETTX (Entasis Therapeutics Holdings)?

Robert Driscoll with lowest potential downside - -$0.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?